Johnson & Johnson (NYSE:JNJ) has linked up with ViiVHealthcare – a specialist HIV company majority-owned byGlaxoSmithKline – to develop a new AIDS medicine combining two drugs in a single tablet. Johnson & Johnson (NYSE:JNJ) net profit margin is 20.90% and weekly performance is -0.63%. On last trading day company shares ended up $102.53. Analysts mean target price for the company is $104.84. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average is 2.60%.
Shares of Novartis AG (NYSE:NVS) have earned an average recommendation of “Hold” from the seven brokerages that are currently covering the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating on the company. Novartis AG (ADR) (NYSE:NVS) shares advanced 0.06% in last trading session and ended the day on $89.34. NVS Gross Margin is 66.50% and its return on assets is 7.80%. Novartis AG (ADR) (NYSE:NVS) quarterly performance is 9.50%.
Abbott Laboratories (NYSE:ABT) declared a quarterly dividend on Friday, June 13th. Shareholders of record on Tuesday, July 15th will be given a dividend of 0.22 per share on Friday, August 15th. This represents a $0.88 dividend on an annualized basis and a yield of 2.21%. Abbott Laboratories (NYSE:ABT) shares moved down -0.05% in last trading session and was closed at $39.79, while trading in range of $39.66-$39.85. Abbott Laboratories (NYSE:ABT) year to date performance is 5.01%.
Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) has launched Takelda combination tablets, a fixed-dose combination (FDC) of low-dose aspirin and Takepron (lansoprazole) for peptic ulcers in Japan. Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) ended the last trading day at $23.27.
AbbVie Inc (NYSE:ABBV), a biopharmaceutical company engaged in the research, development and selling of advanced therapies for complex diseases has recently announced the outcomes of the ALIGN study.The results of the study were presented in Paris at EULAR 2014 Congress. AbbVie Inc (NYSE:ABBV) net profit margin is 21.80% and weekly performance is -1.71%. On last trading day company shares ended up $54.16. Analysts mean target price for the company is $56.80. AbbVie Inc (NYSE:ABBV) distance from 50-day simple moving average is 4.43%.